NAPAAC Program


Wed. Sept



Foyer 200 ABC - Registration open


200 AB - Exhibits open

Grab and Go lunch provided at 12:30 PM


200 C: NAPAAC Welcome & Keynote

This session will open the inaugural conference and will highlight the progress that our specialty has made in the field of oral immunotherapy (OIT) for food. We look forward to an exciting debate about whether or not we can now consider OIT this standard of care and hope to learn more about how to prepare our families for this exciting and often challenging endeavor.

Dr. Paul Turner

OIT: What have we learned?

  1. Understand the immunologic mechanisms involved in oral desensitization
  2. Discuss the risks, benefits, and expected outcomes of oral immunotherapy
  3. Identify risk factors that may impede successful treatment

Dr. Douglas Mack

Preparing families for their OIT journey

  1. Communicate risks, benefits and expected outcome of oral immunotherapy with families
  2. Provide details surrounding daily dosing regimen and adjustments
  3. Educate families how to monitor for adverse effects

TBD vs vs Dr. Arnon Elizur

Pro/Con: OIT is the new standard of care

  1. Discuss limitations of oral immunotherapy with interested families
  2. Identify ideal candidates based upon clinical history, motivation, and desire for treatment

200AB Exhibit Hall: Coffee Break

14:30 – 16:00

ROOM 202: Advanced OIT

These interactive sessions will be organized as breakout groups dealing with beginner and advanced aspects of OIT.  The participant is encouraged to consider their own skill set and experience when choosing a stream. Brief presentations will be followed by interactive discussions amongst the audience and experienced OIT providers.


  • Evidence surrounding different foods
  • Maximizing adherence
  • Approach to adverse effects
  • Who's on call?

Dr. Douglas Mack

14:30 – 16:00

ROOM 204: OIT breakouts




  • Preparing office & staff
  • Treatment of reactions
  • Things I wish I knew before I started

Dr. David Stukus


200AB Exhibit Hall: Coffee Break

16:30 - 18:00

ROOM 200C: Fireside Chat



This informal fireside chat will highlight multiple key questions affecting our field. The first chat will examine key questions surrounding OIT and how our practice can adapt. Each participant will have two minutes to present their response to the fundamental question and the expert panel will then have an informal debate and discussion about these timely topics.


  • Should oral food challenges be mandatory before OIT?
  • What should be the goal of OIT? Protect from accidents vs ad lib?
  • Why do we not start OIT in every new diagnosis food allergy?
  • Do we really need in person visits for build up dosing?
  • How has panel testing affected the process of OIT ?
  • How have antihistamines been incorporated in the OIT reaction management?
18:00 - 19:00

ROOM 200AB: Reception



Join us for a drink and appetizers

Thurs. Sept


7:00 – 7:45

ROOM 200C: SLIT Sponsored Breakfast



Dr. Edwin Kim

This exciting symposium will discuss the evidence and potential for a very low dose of sublingual immunotherapy for the safe and effective treatment of food allergies.


  1. Identify key differences between oral immunotherapy and sublingual immunotherapy
  2. Discuss risks, benefits and expected outcomes of sublingual immunotherapy with families
8:00 – 10:00

ROOM 200C: Keynotes

This session will highlight the area of food allergy prevention and current controversies, as well as areas for improvement.  We will also discuss the management of non-IgE mediated food allergy including FPIES and FPIAP and will debate the role of asthma in food allergy outcomes.




Food Allergy Prevention: What are we missing?

  1. Discuss the evolving evidence surrounding introduction of allergenic foods with families
  2. Proactively address common concerns
  3. Limit unnecessary use of food allergy tests prior to introduction

Dr. Anna Nowak-Wegryzn

The Latest Perspective on FPIES and non-IgE Mediated Food Allergy

  1. Diagnose food protein induced enterocolitis syndrome according to guideline based criteria
  2. Discuss reintroduction of suspected foods as children age
  3. Limit unnecessary dietary avoidance for suspected non-IgE mediated food allergy

Dr. David Stukus vs Dr. Paul Turner

Pro/Con: Asthma is a risk factor for food allergy outcomes  

  1. Assess asthma control and severity for patients with food allergy
  2. Discuss importance of asthma management for patients with food allergy

200AB Exhibit Hall: Coffee Break


ROOM 200C: Keynotes

These novel presentations will update you on the key recent articles on food allergy and critically appraise them! As well, the audience will have an opportunity to decide the fate of a patient with eczema, will they eliminate foods, will they introduce foods early, can they prevent allergy? The future of this child is in your hands.




Dr. Moshe Ben Shoshan, Dr. Katherine Anagnostou, Dr. Elissa Abrams

The most important articles you haven't read this year…and what's wrong with them

  1. Discuss current evidence based approaches to food allergy management with patients
  2. Adapt clinical practice to reflect evolving evidence surrounding food allergy management

Dr. Matthew Greenhawt

Choose Your Own Adventure: The future of this infant with atopic dermatitis is in your hands

  1. Limit use of food allergy tests in infants with atopic dermatitis
  2. Educate families regarding risks of dietary elimination in infants with atopic dermatitis

200AB Exhibit Hall: Grab and Go lunch available


ROOM 200C: Lunch address



Dr. Jay Lieberman

Epinephrine - current use and future strategies

This lunchtime symposium will highlight the current evidence surrounding the use of epinephrine for anaphylaxis, guideline recommendations, options for treatment and future directions.


  1. Educate families regarding common misconceptions surrounding epinephrine autoinjectors
  2. Communicate safety and efficacy of epinephrine for treatment of anaphylaxis
  3. Understand pharmacodynamics of epinephrine through various delivery methods
13:15 - 15:00

ROOM 200C: Keynotes

This exciting afternoon will highlight the future of the use of Biologics in the management of food allergy, the use of antihistamines and other adjunct medications in the management of food allergy.  It will also highlight the challenges of the use of baked products for patients with egg and milk allergy.  Rounding out the discussion will be a review of the psychological challenges facing patients and families with allergy.



Dr. Sharon Chinthrajah

Biologics: Current and Future Applications for Food Allergy Treatment

  1. Describe the immunologic mechanisms underlying food allergy reactions
  2. Extrapolate current understanding of biologic therapy for other allergic conditions to use in food allergy
  3. Identify patient characteristics that may make biologics an amenable therapeutic option

Dr. Antonella Muraro

The role of antihistamines and other adjunctive medications in the food allergy treatment plan

  1. Discuss hesitancy associated with epinephrine with families
  2. Educate families regarding anaphylaxis management and risk for biphasic reactions
  3. Communicate proper use of antihistamines and adjunctive medications during food allergy reactions

TBD vs Matt Greenhawt

Pro/Con: Food ladders should be offered to all milk and egg allergic children

  1. Apply new concepts surrounding risk of reactions from various milk and egg products to clinical recommendations
  2. Educate families regarding variations in allergic potential from various milk and egg products

200AB Exhibit Hall: Coffee break


ROOM 200C: Anaphylaxis, Anxiety & Angst



Dr. Elana Lavine

The Role of Psychology in Food Allergy Management

  1. Discuss anxiety with families during food allergy encounters
  2. Anticipate common concerns and proactively address with families
  3. Identify families that may benefit from additional psychology services

ROOM 200C: Fireside Chat



Dr. Matthew Greenhawt, Dr. Elissa Abrams, Dr. Antonella Muraro, Dr. David Stukus

This informal fireside chat will highlight multiple key questions affecting our field.  The second chat will deal with food allergy challenges, research and future directions. Each participant will have two minutes to present their response to the fundamental question and the expert panel will then have an informal debate and discussion about these timely topics.


  • Does allergy testing have any role in EoE?
  • Does the microbiome yield any answers or is it a distraction?
  • Should we be using component tests on everyone…or no one?
  • Where are we going to be in 10 years with food allergy therapy?
  • Infants with mild skin symptoms after ingestion and mild/moderate IgE: Feed or avoid?
  • Do all allergic reactions need epinephrine, or can some be managed with antihistamines?